October 30th, 2009
The first “Free to Breathe” run/walk to benefit lung cancer is at 8 a.m. Saturday, Nov. 7, at Hendricks Avenue Elementary School, 3400 Hendricks Ave. Registration starts at 7 a.m. Awards will be given to the top male and female finishers in divisions ranging from age 10 and under to 70 and older.
It will consist of a 5K run/walk and a 1-mile walk. Julia Stroud, a lung cancer survivor and advocate, said in a news release that more than 400 lung cancer survivors and supporters have registered.
Data from the National Lung Cancer Partnership indicates one in 13 men and one in 16 women will be diagnosed with lung cancer in America, killing more people than breast, colon, prostate, liver, kidney and melanoma cancers combined, the release said.
October 30th, 2009
On Thursday, Nov. 5 at 6:30 p.m., the upper portion of Boston’s Prudential Building will be glowing blue. The third annual event will help to shine a light on lung cancer — something Amesbury resident Diane Legg has been trying to do since her diagnosis in 2005.
“I didn’t think I would be here to see my youngest son start school,” said Legg, who was diagnosed with lung cancer after having a routine CT scan for a pulled muscle in her back.
October 30th, 2009
Combining two targeted cancer therapies may overcome the resistance that some lung tumors develop during treatment, according to a recent report in the Journal of Clinical Investigation.
The study, which tested the drug combo in mouse models of lung cancer, supports moving forward with clinical trials in patients with lung cancer.
October 30th, 2009
Celera said today that it has licensed the rights to use Medical Therapies Limited’s patent portfolio for the protein midkine in its lung cancer diagnostics programs.
Under the exclusive license with Sydney-based Medical Therapies, Celera will pay up front and milestone payments and royalties on product sales over the life of the patents. Specific financial details were not disclosed by the firms.
October 30th, 2009
Scientists from UT Southwestern Medical Center have suggested a novel therapeutic strategy that would completely eradicate lung cancer.
Researchers Pier Paolo Scaglioni and Georgia Konstantinidou have shown that using an investigative drug called BEZ235 in combination with low-dose radiation successfully eliminated non-small cell lung (NSCL) cancer in mice.
October 29th, 2009
The Mayor of the City of Cairo, Illinois has issued the following proclamation relative to November being Lung Cancer Awareness Month.
October 29th, 2009
A national television initiative to raise awareness of lung cancer and asbestos cancer risks features pathologist and lung cancer advocate Deborah Morosini, M.D. The TV spot is being sponsored by asbestos and mesothelioma lawyers Baron & Budd, P.C.
October 29th, 2009
In a study appearing in the October issue of Cancer Research, UT Southwestern researchers found that if they administered BEZ235 before they damaged the DNA of tumor cells with otherwise nontoxic radiation, the drug blocked the pro-survival actions of a protein called PI3K, which normally springs into action to keep tumor cells alive while they repair DNA damage.
October 29th, 2009
The Duke Cancer Center and The North Carolina Lung Cancer Partnership are proud to announce the third annual Free to Breathe Lung Cancer 5K on November 7th at the North Carolina State University Centennial Campus. The North Carolina Lung Cancer Partnership is committed to decreasing deaths due to lung cancer.
October 28th, 2009
I AM responding to the physician whose letter proclaimed that CT scans were a proven waste of resources in screening for lung cancer (“State’s high court oversteps in ruling on cancer screenings,’’ Letters, Oct. 24). I am assuming that his mother did not die of lung cancer 35 years after she had quit smoking. Kara Kennedy would probably not be alive today except that her cancer was caught on a routine X-ray.
